counter CSL loses $2.4bn in value, other pharmaceuticals tumble after Donald Trump’s 100pc tariff move – Forsething

CSL loses $2.4bn in value, other pharmaceuticals tumble after Donald Trump’s 100pc tariff move

Australia’s leading biotech has shed $2.4bn after Donald Trump’s shock tariff move on pharmaceuticals not made in the US.

About admin